Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

c-myc promoter (Del 2) Citations (3)

Originally described in: Identification of c-MYC as a target of the APC pathway.
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW Science. 1998 Sep 4. 281(5382):1509-12.
PubMed Journal

Articles Citing c-myc promoter (Del 2)

Articles
Effects of a glycogen synthase kinase-3beta inhibitor (LiCl) on c-myc protein in intervertebral disc cells. Hiyama A, Sakai D, Arai F, Nakajima D, Yokoyama K, Mochida J. J Cell Biochem. 2011 Oct;112(10):2974-86. doi: 10.1002/jcb.23217. PubMed
p63 regulates human keratinocyte proliferation via MYC-regulated gene network and differentiation commitment through cell adhesion-related gene network. Wu N, Rollin J, Masse I, Lamartine J, Gidrol X. J Biol Chem. 2012 Feb 17;287(8):5627-38. doi: 10.1074/jbc.M111.328120. Epub 2011 Dec 19. PubMed
Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma. Yamaki T, Suenaga Y, Iuchi T, Alagu J, Takatori A, Itami M, Araki A, Ohira M, Inoue M, Kageyama H, Yokoi S, Saeki N, Nakagawara A. Sci Rep. 2013;3:1160. doi: 10.1038/srep01160. Epub 2013 Jan 29. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.